baber/WOPTO huggingface dataset:
Patent AU-2017206012-A1 (AU)
Title: Reduction of high molecular weight species, acidic charge species, and fragments in a monoclonal antibody composition
Inventor: SANTORO MARC
IPC: C07K16/24
Filed: 2017-01-05
Abstract: Alterations in bioreactor cell culture feeding to an extended or continuous feed following an initial period of no feeding reduces the level of high molecular weight, acid charge, and fragment species of monoclonal antibodies expressed in the culture, and enhances the level of afucosylated species of monoclonal antibodies expressed in the culture. Regular fucose infusions following an initial period of no feed media infusion reduces the level of afucosylated species of monoclonal antibodies expressed in the culture. Cell culture manipulation may be used to modulate the level of species of monoclonal antibodies.
Patent AU-2017207521-A1 (AU)
Title: Process for preparation of polyethylene nanocomposite
Inventor: ADETUNJI PHILIP
IPC: B29C48/32
Filed: 2017-01-13
Abstract: The invention provides a process for preparation of a polyethylene nanocomposite comprising dispersing a base polyethylene resin and planar carbon nanoparticles in an inert liquid at conditions under which the base polyethylene resin is not solubilised in the inert liquid, and removing an amount of the liquid sufficient to provide a dispersion of the planar carbon nanoparticles in the base polyethylene resin.
Patent AU-2017208269-A1 (AU)
Title: Surface enhanced pulp fibers, methods of making surface enhanced pulp fibers, products incorporating surface enhanced pulp fibers, and methods of making products incorporating surface enhanced pulp fibers
Inventor: PANDE HARSHAD
IPC: D21H11/16
Filed: 2017-07-26
Abstract: Abstract Various embodiments of the present invention relate to surface enhanced pulp fibers, various products incorporating surface enhanced pulp fibers, and methods and systems for producing surface enhanced pulp fibers. Various embodiments of surface enhanced pulp fibers have significantly increased surface areas compared to conventional refined fibers while advantageously minimizing reductions in length following refinement. The surface enhanced pulp fibers can be incorporated into a number of products that might benefit from such properties including, for example, paper products, paperboard products, fiber cement boards, fiber reinforced plastics, fluff pulps, hydrogels, cellulose acetate products, and carboxymethyl cellulose products. In some embodiments, a plurality of surface enhanced pulp fibers have a length weighted average fiber length of at least about 0.3 millimeters and an average hydrodynamic specific surface area of at least about 10 square meters per gram, wherein the number of surface enhanced pulp fibers is at least 12,000 fibers/milligram on an oven-dry basis. See Fig. 1. WO 2014/031737 PCT/US20131055971 1,/2 -0 c co 0 co C)) o -0 C: C:)-0) co 5CJ -- -- -- -- - C: w
Patent AU-2017210921-A1 (AU)
Title: Composition and combined medication method for treating enterovirus infection
Inventor: ZOU GANG
IPC: A61K45/06
Filed: 2017-01-11
Abstract: The present invention provides a composition and a combined medication method for treating an enterovirus infection. In particular, the present invention provides a composition for inhibiting enteroviruses, wherein the composition at least comprises an inhibitor of a 3D virus protein and an inhibitor of a capsid protein, or a combination of an inhibitor of a 3C protein and an inhibitor of a 3A protein.
Patent AU-2017212886-A1 (AU)
Title: Alpha-gel formation composition and alpha-gel composition
Inventor: MIYAHARA REIJI
IPC: A61K8/63
Filed: 2017-01-06
Abstract: The present invention addresses the problem of providing an α-gel formation composition and an α-gel composition that uses said α-gel formation composition that are highly stable and that do not become colored, deposit crystals, etc. over time. An α-gel composition that includes (A) 25-50 mass% of one or more higher aliphatic alcohol and/or higher fatty acid that has 16 or more carbons, (B) 40-70 mass% of a specific polyoxyethylene sterol ether, and (C) 5-20 mass% of a specific polyoxyethylene dialkyl ester and/or ether. The α-gel composition is generated by adding water.
Patent AU-2017215345-A1 (AU)
Title: Compositions of influenza hemagglutinin with heterologous epitopes and/or altered maturation cleavage sites
Inventor: LUO CHUN
IPC: A61P31/16
Filed: 2017-02-02
Abstract: Modified forms of hemagglutinin (HA) protein including those with modified immunodominant regions and with modified maturation cleavage sites, and virus and virus-like particles containing them are disclosed.
Patent AU-2017222396-A1 (AU)
Title: Nucleic acid constructs for producing retroviral vectors
Inventor: PULÉ MARTIN
IPC: C12N15/86
Filed: 2017-02-24
Abstract: The present invention relates to a nucleic acid construct comprising: (i) a first nucleic acid sequence which either comprises a retroviral transfer vector or which encodes a retroviral protein; and (ii) a second nucleic acid sequence which encodes a detectable marker which is a cell surface protein comprising an extracellular domain and a membrane targeting domain.
Patent AU-2017258857-A1 (AU)
Title: Subfamily E simian adenovirus A1309, A1321, A1325, A1295 and A1322 and uses thereof
Inventor: SOUMITRA ROY
IPC: C07K14/075
Filed: 2017-11-08
Abstract: I: \amt\Interwoven\NRPortbl\DCC\AMT\15969727_l.docx-8/ It2017 Provided herein are recombinant vectors comprising simian adenovirus sequences of SAdV-A1309, SAdV-A1321, SAdV-A1325, SAdV-A1295, SAdV-A1316 and SAdV-A1322, and heterologous genes under the control of regulatory sequences. Cell lines which express simian adenovirus genes are also disclosed. Methods of using the vectors and cell lines are provided.
Patent AU-2017262651-A1 (AU)
Title: Personal care products and applicators
Inventor: GRAHAM HEIDI
IPC: A45D40/04
Filed: 2017-05-09
Abstract: In one aspect of the subject invention, a personal care product is provided herein including an applicator having a body, with a dispensing opening, and a support surface, within the body, which is advanceable towards the dispensing opening. A layer of solid personal care is disposed on the support surface which defines an exposed face bounded by spaced-apart first and second edges extending between first and second ends. The exposed face also defines a first inclined face extending from the first end to a first location between the first and second ends, and a second inclined surface, extending from the second end to a second location between the first and second ends. The first and second inclined faces define an included angle which is less than 180 degrees. Advantageously, with the subject invention, differently dimensioned and angularly disposed surfaces may be defined suitable for applying the personal care to different portions of the body.
Patent AU-2017290894-A1 (AU)
Title: Compounds and methods for modulating RNA function
Inventor: PETTER RUSSELL C
IPC: A61K31/496
Filed: 2017-06-30
Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
Patent AU-2017293647-A1 (AU)
Title: Electrolytic brush assembly
Inventor: WHITE CLIVE
IPC: A46B11/02
Filed: 2017-05-08
Abstract: Disclosed herein is an electrolytic brush assembly comprising a handle assembly; a shroud extending from the handle assembly, the shroud having an aperture at a distal end thereof; a brush connecting assembly for releasably connecting a brush to the handle assembly whereby the brush extends through the aperture of the shroud and a fluid delivery assembly. The handle assembly comprises an adjustment sub-assembly for selectively moving the brush connecting assembly and a brush connected thereto relative to the handle assembly and the aperture of the shroud. The fluid delivery assembly delivers electrolytic fluid to the proximity of the brush, optionally under closed loop control.
Patent AU-2017303719-A1 (AU)
Title: Terminal apparatus, base station apparatus, communication method, and integrated circuit
Inventor: SUZUKI SHOICHI
IPC: H04W52/14
Filed: 2017-07-26
Abstract: A terminal device performs transmission of an uplink physical channel including a transport block, and sets a transmission power for transmitting the uplink physical channel on the basis of at least the following first element and/or second element. First element: A signal waveform of the uplink physical channel. Second element: A sub-carrier interval of the uplink physical channel.
Patent AU-2017314768-A1 (AU)
Title: A gas purifying apparatus
Inventor: VOSSOUGHI KHAZAEI SAEID
IPC: B03C3/38
Filed: 2017-08-25
Abstract: A gas purifying apparatus, including: at least one cylindrical ground electrode configured to receive gas flowing therethrough; a discharge electrode disposed centrally within each of the at least one cylindrical ground electrode; and a power supply electrically connected to the discharge electrode and the at least one cylindrical ground electrode so as to produce an electric field and a corona discharge from the discharge electrode to a corresponding cylindrical ground electrode to generate ions and free electrons into the gas to ionise substances in the gas for gas purification, wherein the discharge electrode and the corresponding cylindrical ground electrode form at least one plasma chamber when power from the power supply is applied, and wherein the discharge electrode includes: at least one annular plate having an outer edge extending towards the corresponding cylindrical ground electrode, and whereby the electric field produced between the edge and the corresponding cylindrical ground electrode is uniform such that the gas flowing through the plasma chamber is exposed to the uniform electric field and to the ions and free electrons for gas purification.
Patent AU-2017324053-A1 (AU)
Title: Diagnostics systems and methods
Inventor: GALEN PETER
IPC: G01N35/00
Filed: 2017-05-18
Abstract: A point-of-care diagnostic system that includes a cartridge and a reader. The cartridge can contain a patient sample, such as a blood sample. The cartridge is inserted into the reader and the patient sample is analyzed. The reader contains various analysis systems, such as a magneto- optical system that measures a light transmission differential through the patient sample in varying magnetic fields. The reader can process data from the various patient sample analysis to provide interpretative results indicative of a disease, infection and/or condition of the patient.
Patent AU-2017339881-A1 (AU)
Title: Mouthfeel blends for low and non-caloric beverages
Inventor: BRIJWANI KHUSHAL
IPC: A23L2/60
Filed: 2017-10-03
Abstract: The present disclosure provides a composition for improving mouthfeel of beverages, comprising: a hydrolyzed beta-glucan characterized by an average molecular weight (Mw) of about 50,000 to 350,000; and a hydrolyzed arabinoxylan, characterized by an average molecular weight (Mw) of about 50,000 to about 350,000. Also provided are methods of improving the mouthfeel of a beverage product by adding to it a composition of the disclosure.
Patent AU-2018202065-A1 (AU)
Title: Antimicrobial Compounds And Methods Of Making And Using The Same
Inventor: DUFFY ERIN M
IPC: C07D251/30
Filed: 2018-03-23
Abstract: The present invention relates generally to the field of antimicrobial compounds and to methods of making and using them. These compounds are useful for treating, preventing, and reducing the risk of microbial infections in humans and animals.
Patent AU-2018203476-A1 (AU)
Title: Vodka made with water infused with a high concentration of molecular hydrogen
Inventor: AKHOUNOV ANATOLI
IPC: C12G3/08
Filed: 2018-05-16
Abstract: Vodka made with water infused with a high concentration of molecular hydrogen and that can be used in the alcohol beverages production industry. Before bottling, the solution is infused with molecular hydrogen (H2), which acts as a powerful antioxidant. A new vodka called H2V Vodka (hydrogen vodka) is about 37-43 % of alcohol in specially treated water, Hierochloe Odorata 0.07-0.08 vol% (the first extract according to "Formulas of alcoholic beverages and vodka" Moscow, Ministry of Food Industry 1981 (page 300)), 0.02 -0.03 vol% hazelnut extract in form accepted by the food safety authorities and approximately 2.3 -4.6 mg/L of sodium bicarbonate.
Patent AU-2018203478-A1 (AU)
Title: Ly75 as cancer therapeutic and diagnostic target
Inventor: ACKROYD JAMES EDWARD
IPC: A61P35/00
Filed: 2018-05-17
Abstract: The present invention provides methods and compositions for treatment, screening, diagnosis and prognosis of cancer, such as lymphoma, myeloma, leukaemia, thyroid cancer, bladder cancer, breast cancer, gastric cancer, esophagus cancer, head and neck cancer and skin cancer, for monitoring the 5 effectiveness of cancer, such as lymphoma, myeloma, leukaemia, thyroid cancer, bladder cancer, breast cancer, gastric cancer, esophagus cancer, head and neck cancer and skin cancer treatment, and for drug development.
Patent AU-2018215056-A1 (AU)
Title: D-methadone and its derivatives for use in the treatment of disorders of the nervous system
Inventor: MANFREDI PAOLO L
IPC: A61P25/00
Filed: 2018-01-31
Abstract: The present invention relates to a method of treating or preventing cellular dysfunction and death caused by genetic, degenerative, toxic, traumatic, ischemic, infectious, neoplastic and inflammatory diseases and aging - and their neurological symptoms and manifestations, which includes administering d-methadone, beta-d-methadol, alpha-l-methadol, beta-l-methadol, alpha-d-methadol, acetylmethadol, d-alpha-acetylmethadol, l-alpha-acetylmethadol, beta-d-acetylmethadol, beta-l-acetylmethadol, d-alpha-normethadol, l-alpha normethadol, noracetylmethadol, dinoracetylmethadol, methadol, normethadol, dinormethadol, EDDP, EMDP, d-isomethadone, normethadone, N-methyl-methadone, N-methyl-d-methadone, N-methyl-l-methadone, l-moramide, levopropoxyphene, pharmaceutically acceptable salts, or mixtures thereof, including deuterated and tritium analogues, whether isolated from its enantiomer or synthesized de novo.
Patent AU-2018232211-A1 (AU)
Title: Radioactive fluorine-labeling precursor compound and method for producing radioactive fluorine-labeled compound using same
Inventor: KIRIU Masato
IPC: C07B59/00
Filed: 2018-03-05
Abstract: Provided is a labeled precursor compound represented by formula (2). (In the formula, S represents a substrate, L represents a C1-6 linear alkyl group which may contain an ether group, R
Patent AU-2018253450-A1 (AU)
Title: Method for preparing azoxystrobin intermediates
Inventor: WANG HAISHUI
IPC: C07D239/34
Filed: 2018-10-22
Abstract: Abstract The present invention provides a method for preparing azoxystrobin intermediates, comprising reacting compound A and dichloropyrimidine in the presence of a trimethylamine catalyst with the addition of a sodium methoxide solution in methanol or the addition of sodium methoxide and methanol separately to produce a mixture of compound B and compound C. Azoxystrobin intermediate compound B and compound C are synthesized from compound A in the present invention, which is catalyzed by using a trimethylamine catalyst, allowing the reaction to have high efficiency and high yield. In addition, the trimethylamine catalyst has a low boiling point and thus can be easily recycled so that the ammoniacal nitrogen content in wastewater can be reduced, and the difficulties and high costs for wastewater processing can be also reduced. The recycled trimethylamine catalyst can be reused in preparing intermediate compound B, which also has a high catalytic effect and can also achieve a high product yield. The method of the present invention has significant synthetical cost advantages and is suitable for industrial production.
Patent AU-2018253534-A1 (AU)
Title: Information processing device and information processing system
Inventor: SUZUKI YOSHIHIKO
IPC: G01C11/04
Filed: 2018-10-24
Abstract: Generally, an information processing device according to one embodiment includes storage, a receiver, a detector, an extractor, and a position specifier. The storage stores therein, imaging positional information indicating, identification information on a landmark set, and registration landmark information, in association with one another. The receiver receives a captured image for position specification from an onboard device. The extractor extracts imaging landmark information serving as information on a detected landmark from the captured image for position specification. The position specifier specifies the position indicated by the imaging positional information associated with the identification information on the landmark set including the registration landmark information similar to the imaging landmark information as the position of a vehicle at time when the captured image for position specification is taken.
Patent AU-2018264137-A1 (AU)
Title: Intelligent code quality monitoring
Inventor: KHANDALKAR PRASHANT NARAYANRAO
IPC: G06Q10/10
Filed: 2018-11-16
Abstract: A device may receive, from a user device, a request for one or more code quality assessments of a program. The device may obtain authorization to access one or more environments associated with the program. The device may obtain one or more tokens that are associated with the one or more environments. The device may obtain a set of test classes for the program. The device may determine one or more code quality assessment scores by performing, for the program, a code quality assessment of the one or more code quality assessments. The device may perform the code quality assessment by accessing the one or more environments using the one or more tokens, executing the set of test classes in each environment, and determining the one or more code quality assessment scores. The device may provide the one or more code quality assessment scores to the user device. >,C Z= C) C/)) 07o E Ew ccU,*.E cn a) U, cC *.n U)n a 0 c
Patent AU-2018268001-A1 (AU)
Title: Kits, methods and their uses for detecting cell-cell interactions in a sample kits
Inventor: LARIJANI BANAFSHE
IPC: G01N33/574
Filed: 2018-05-16
Abstract: The present invention provides an in vitro method for detecting cell-cell interactions and associated kits and uses, where the method comprises: (a) at least two primary binding agents, wherein the first primary binding agent binds to a first molecule on a first cell and the second primary binding agent binds to a second molecule on a second cell, and wherein the first and second primary binding agents are immunologically distinct; (b) at least two secondary binding agents, wherein a first secondary binding agent binds to the first primary binding agent; and a second secondary binding agent binds the second primary binding agent, wherein the first secondary binding agent does not bind the second primary binding agent and the second secondary binding agent does not buy the first primary binding agent; and wherein: (i) the first secondary binding agent is labelled with a FRET donor and the second secondary binding agent is labelled with a FRET acceptor; (ii) the first and second secondary binding agents are conjugated or fused to a DNA sequence, wherein the DNA sequences are different and ligate to form a circle and are amplified by rolling circle DNA amplification, and are bound by externally applied fluorescently labelled DNA probes complimentary to that of the amplified DNA sequences; or (iii) the first secondary binding agent is labelled with a FRET donor and the second secondary binding agent is fused to an enzyme which reacts with a conjugate comprising a FRET acceptor and a substrate specific enzyme to form an activated conjugate that binds to electron rich moieties on a molecular surface adjacent to the enzyme; wherein the method comprises: i. contacting an isolated sample containing cells with the at least two primary binding agents; ii. contacting the sample with the at least two secondary binding agents; iii. performing a wash step; iv. detecting the interaction between the secondary binding agents.
Patent AU-2018270247-A1 (AU)
Title: Pre-cast segment for tunnels and method for producing and monitoring said pre-cast segment
Inventor: MANCINI GIUSEPPE
IPC: E21D11/08
Filed: 2018-05-15
Abstract: Pre-cast segment for a reinforced concrete tunnel, comprising an arcuate structure having a reinforcement and a cement agglomerate that is designed to cover structurally repeated annular tunnel segments for modules corresponding to a fraction of the cross section thereof, said arcuate structure comprising respective opposite radial faces that lie on planes that are angularly spaced apart from one another and passing through a longitudinal axis of the tunnel, respective opposite circumferential faces that lie on surfaces perpendicular to said longitudinal axis and are spaced apart along said longitudinal axis, respective opposite longitudinal faces that lie on surfaces that are parallel to said longitudinal axis, said radial faces being adapted to be moved towards respective radial faces of adjacent segments in order to form an annular tunnel portion, said circumferential faces being adapted to be moved towards respective circumferential faces of adjacent segments in order to form a linear extent of said tunnel along said longitudinal axis and an outer longitudinal face being at a greater distance than an inner longitudinal face from said longitudinal axis, is placed in contact with the ground of said tunnel, wherein at least one investigation device is embedded in said arcuate structure of said pre-cast segment at a predetermined distance from at least one of said radial, circumferential or longitudinal faces, so as to detect predetermined structural parameters.
Patent AU-2018277966-A1 (AU)
Title: Functional structure and production method for functional structure
Inventor: MASUDA TAKAO
IPC: B01J29/68
Filed: 2018-05-31
Abstract: Provided is a functional structure that suppresses degradation of the function of a functional substance and can thereby achieve long life, that does not necessitate complicated replacement work, and that makes it possible to conserve resources. A functional structure (1) that comprises: a skeleton (10) that has a porous structure that is configured from a zeolite-type compound; and at least one functional substance (20) that is inside the skeleton (10). The skeleton (10) has passages (11) that communicate with each other, and the functional substance (20) is in at least the passages (11) of the skeleton (10).
Patent AU-2018337034-A1 (AU)
Title: Lean parsing: a natural language processing system and method for parsing domain-specific languages
Inventor: MUKHERJEE SAIKAT
IPC: G06Q40/00
Filed: 2018-09-18
Abstract: A method and system parses natural language in a unique way, determining important words pertaining to a text corpus of a particular genre, such as tax preparation. Sentences extracted from instructions or forms pertaining to tax preparation, for example are parsed to determine word groups forming various parts of speech, and then are processed to exclude words on an exclusion list and word groups that don't meet predetermined criteria. From the resulting data, synonyms are replaced with a common functional operator and the resulting sentence text is analyzed against predetermined patterns to determine one or more functions to be used in a document preparation system.